Newsletter - Oak Leaf Manor

The Mental Health Crisis: Why Immediate and Affordable Care Needs to Become the Norm March 24, 2025
Our mental health system is not designed to treat people in crisis. Instead of being administered right away and effectively, it shoves patients through a maze of barriers. If we are serious about saving lives, then we must reconsider how mental health care is administered. The post The Mental Health Crisis: Why Immediate and Affordable […]
How Are Hospitals Faring Financially in 2025? March 23, 2025
Hospitals started 2025 with a stable financial performance driven by strong patient volumes, but rising costs for drugs, supplies, and services continue to put major pressure on margins. The post How Are Hospitals Faring Financially in 2025? appeared first on MedCity News.
Aledade, Humana Expand Value-Based Partnership to Support FQHCs and Rural Health Clinics March 23, 2025
An expanded partnership with Humana will help Aledade’s FQHC and rural health clinic partners share savings in Medicare Advantage. The post Aledade, Humana Expand Value-Based Partnership to Support FQHCs and Rural Health Clinics appeared first on MedCity News.
Novartis Nabs First FDA Nod in Rare Kidney Disease, But Apellis Pharma Is on Its Heels March 23, 2025
Novartis’s Fabhalta is the first FDA-approved therapy for C3 glomerulopathy. But Apellis Pharmaceuticals’ Empaveli has superior clinical data, and that drug has been submitted for FDA review in the same rare kidney disease as well as another one that does not yet have an approved therapy. The post Novartis Nabs First FDA Nod in Rare […]
Evolving Capacity to Meet Advanced Biologics Therapies March 23, 2025
Creating adequate capacity for any therapeutic can be challenging, and the specialized technologies for manufacturing complex biologics require flexibility and agility in production processes. Here’s how contract development and manufacturing organizations (CDMOs) ensure that biopharmaceutical companies have a partner with the speed, flexibility, and expertise necessary for successful drug development and manufacturing. The post Evolving […]